Cheapest Semaglutide Provider: Why the Big Telehealth Brands Cost More Than You Think

If you’ve searched for semaglutide or tirzepatide online, you’ve probably landed on ads from Hims & Hers, Ro, Henry Meds, or LifeMD. They’re everywhere — polished apps, celebrity marketing, and headline prices that look competitive at first glance. But there’s a real question worth asking before you sign up with any of them: what are you actually paying for, every single month, whether you use it or not?

The Subscription Trap Hiding in “Affordable” GLP-1 Pricing

Here’s what all four of those platforms have in common: a recurring membership or consultation fee, charged separately from your actual medication.

• Hims & Hers charges a $39 first-month membership that renews at $149/month — with medication priced on top of that, separately.
• LifeMD charges a consultation/membership fee (commonly cited around $30–$100) plus medication cost, with total monthly spend reported anywhere from roughly $150 to well over $700 depending on the medication and tier.
• Henry Meds and Ro both advertise a low headline price, but independent reviewers consistently report the real ongoing cost lands meaningfully higher once dosing tier and continued access are factored in — figures vary widely by source and change often.

We’re deliberately not quoting a single “gotcha” dollar figure for any of them here, because — and this is worth knowing as a patient, not just for this comparison — pricing in this space changes fast. Multiple independent trackers that check these platforms weekly show real month-to-month swings, and in early 2026 the FDA issued warning letters to more than 30 companies offering compounded GLP-1 medications, reshaping the market in real time. Any specific number we could print today might already be outdated by the time you read this. What doesn’t change as quickly is the structure — and that structure is what actually determines your real cost.

In practice, a membership-based structure often means paying a monthly “access fee” on top of your prescription cost, whether or not your dose changes, whether or not you need a check-in that month, and often for as long as you stay enrolled. Cancel, and you may lose access entirely — not just to the medication, but to the account, your records, and any progress tracking you built up.

Why We Do It Differently

At HCG Diet Miami, we use a straightforward pay-per-vial model. You pay for your medication — a real, multi-week supply, sourced through a licensed U.S. compounding pharmacy — and nothing else. No recurring membership. No access fee stacked on top of your prescription. No surprise charge if you decide to pause or stop.

Because we sell vials upfront rather than billing a subscription every 30 days, your true monthly cost is tied directly to your actual dose — not a flat corporate rate designed around the platform’s average customer. For many patients, especially those just starting out on a lower dose, this structure works out to genuinely lower total cost than the big telehealth brands, without sacrificing the medical oversight that matters.

The Regulatory Landscape Has Shifted — and It Matters

This isn’t just a pricing philosophy question anymore. In early 2026, the FDA issued warning letters to more than 30 companies offering compounded GLP-1 medications, and at least one major national telehealth brand has since pulled back from offering compounded semaglutide altogether. The compounded GLP-1 market is genuinely in flux right now, with real regulatory and legal action reshaping who offers what, and at what price.

We think that makes transparency more important, not less. Every patient deserves to know exactly what pharmacy is compounding their medication, under what oversight, and what they’re actually agreeing to pay before they commit — not after the first “promotional” month ends.

What to Actually Compare

When you’re evaluating any GLP-1 provider — us included — here’s what we’d suggest checking, rather than just the advertised starting price:

• Is there a separate membership or subscription fee, charged in addition to the medication itself?
• Does the price change after an introductory period, and is that clearly disclosed upfront?
• Where is the medication actually compounded, and is that pharmacy licensed and accredited?
• What happens if you cancel — do you lose access to your provider, your records, or your remaining supply?

Our Commitment

We built our pricing around a simple idea: you should be able to see exactly what you’re paying for, with no membership fee hiding behind a flashy app. If you’re comparing your options for semaglutide or tirzepatide, we’d encourage you to ask every provider — including us — the questions above before you commit.

Sources: FDA warning letters to compounded GLP-1 companies, reported by Telehealth Ally, April 2026. Pricing structures verified against GLP Chart’s weekly-tracked pricing index and independent provider reviews, as of August 2026.

This article is for general informational purposes and isn’t a substitute for personalized medical advice. Pricing for any provider mentioned, including our own, is subject to change — please confirm current pricing directly before enrolling with any provider.